ZTLIDO Drug Patent Profile
✉ Email this page to a colleague
When do Ztlido patents expire, and when can generic versions of Ztlido launch?
Ztlido is a drug marketed by Scilex Pharms and is included in one NDA. There are eight patents protecting this drug and one Paragraph IV challenge.
This drug has thirty-eight patent family members in nineteen countries.
The generic ingredient in ZTLIDO is lidocaine. There are twenty-nine drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the lidocaine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ztlido
A generic version of ZTLIDO was approved as lidocaine by ACTAVIS LABS UT INC on August 23rd, 2012.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ZTLIDO?
- What are the global sales for ZTLIDO?
- What is Average Wholesale Price for ZTLIDO?
Summary for ZTLIDO
International Patents: | 38 |
US Patents: | 8 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 132 |
Clinical Trials: | 8 |
Patent Applications: | 4,455 |
Drug Prices: | Drug price information for ZTLIDO |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ZTLIDO |
What excipients (inactive ingredients) are in ZTLIDO? | ZTLIDO excipients list |
DailyMed Link: | ZTLIDO at DailyMed |


Recent Clinical Trials for ZTLIDO
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Scilex Pharmaceuticals, Inc. | Phase 1 |
Pharmacology for ZTLIDO
Drug Class | Amide Local Anesthetic Antiarrhythmic |
Physiological Effect | Local Anesthesia |
US Patents and Regulatory Information for ZTLIDO
ZTLIDO is protected by eight US patents.
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Scilex Pharms | ZTLIDO | lidocaine | PATCH;TOPICAL | 207962-001 | Feb 28, 2018 | RX | Yes | Yes | ⤷ Try for Free | ⤷ Try for Free | Y | ⤷ Try for Free | |||
Scilex Pharms | ZTLIDO | lidocaine | PATCH;TOPICAL | 207962-001 | Feb 28, 2018 | RX | Yes | Yes | ⤷ Try for Free | ⤷ Try for Free | Y | ⤷ Try for Free | |||
Scilex Pharms | ZTLIDO | lidocaine | PATCH;TOPICAL | 207962-001 | Feb 28, 2018 | RX | Yes | Yes | ⤷ Try for Free | ⤷ Try for Free | Y | ⤷ Try for Free | |||
Scilex Pharms | ZTLIDO | lidocaine | PATCH;TOPICAL | 207962-001 | Feb 28, 2018 | RX | Yes | Yes | ⤷ Try for Free | ⤷ Try for Free | Y | ⤷ Try for Free | |||
Scilex Pharms | ZTLIDO | lidocaine | PATCH;TOPICAL | 207962-001 | Feb 28, 2018 | RX | Yes | Yes | ⤷ Try for Free | ⤷ Try for Free | Y | ⤷ Try for Free | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for ZTLIDO
See the table below for patents covering ZTLIDO around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Brazil | 122021017591 | Uso de lidocaína para a preparação de um curativo adesivo não-aquoso para o tratamento de dor | ⤷ Try for Free |
Turkey | 201810942 | ⤷ Try for Free | |
Spain | 2845524 | ⤷ Try for Free | |
European Patent Office | 2823815 | PATCH NON AQUEUX (NON-AQUEOUS PATCH) | ⤷ Try for Free |
Mexico | 349572 | PARCHE NO ACUOSO. (NON-AQUEOUS PATCH.) | ⤷ Try for Free |
>Country | >Patent Number | >Title | >Estimated Expiration |
Market Dynamics and Financial Trajectory for ZTlido®
More… ↓